Annovis Bio (ANVS)

• Market cap: $48.9M
• 1 day: 0.96%
• 5 days: -0.47%
• 1 month: 1.45%
• 3 months: -23.08%
• 6 months: 40.94%
• Year to date: -58.9%
• 1 year: -77.37%
• 5 years: -51.83%
• 10 years: -78.1%
• Sector: Healthcare
• Industry: Biotechnology

About: Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Employees: 6